SUNPHARMA - IntraDay Trade Analysis with Live Signals

Last Updated Time : 19 Sept 25, 2:16 pm

IntraDay Trade Rating: 3.9

📊 Intraday Trading Analysis for SUNPHARMA

✅ Strengths

Solid Fundamentals: ROCE (16.8%) and ROE (17.8%) reflect strong operational efficiency. EPS of ₹20 supports valuation.

Price Support Zone: Trading above 50-DMA (₹1,632) and near 200-DMA (₹1,677), offering technical support.

DII Accumulation: +0.80% increase in domestic institutional holding signals confidence.

Low Leverage: Debt-to-equity ratio of 0.46 is healthy for a large-cap pharma stock.

⚠️ Weaknesses

MACD Negative (-3.61): Indicates weakening momentum.

RSI Neutral (59.5): No strong directional bias.

Volume Flat: Current volume (19.38L) is slightly below 1-week average (19.94L), suggesting moderate interest.

High P/E (79.4) vs Industry PE (33.4): Valuation is stretched.

Profit Drop: PAT fell from ₹2,000 Cr to ₹936 Cr, which may limit upside.

🎯 Intraday Trade Plan

📌 Optimal Buy Price

₹1,645–₹1,650 (near current price, ideally on a volume uptick and MACD flattening)

📈 Profit-Taking Levels

Target 1: ₹1,660 (momentum extension)

Target 2: ₹1,675–₹1,680 (approaching 200-DMA resistance)

📉 Stop-Loss

₹1,630 (below 50-DMA and psychological support)

⏱️ If Already Holding Today

🔄 Exit Signals

RSI drops below 56

MACD continues to diverge negatively

Price rejection near ₹1,660–₹1,675 after multiple attempts

This setup favors cautious scalping with tight risk control. Momentum is soft, so any long position should be volume-confirmed and nimble. Let me know if you'd like to track this live with a chart overlay or volume heatmap.

Edit in a page